Fas gene promoter-670 polymorphism (A/G) is associated with cervical carcinogenesis

被引:40
作者
Ueda, M
Hung, YC
Terai, Y
Yamaguchi, H
Saito, J
Nunobiki, O
Noda, S
Ueki, M
机构
[1] Osaka Med Coll, Dept Obstet & Gynecol, Osaka 5698686, Japan
[2] China Med Coll, Dept Obstet & Gynecol, Taichung, Taiwan
[3] Kansai Med Coll, Dept Obstet & Gynecol, Osaka, Japan
[4] Osaka Canc Prevent Ctr, Osaka, Japan
关键词
Fas; polymorphism; SIL; cervical carcinogenesis;
D O I
10.1016/j.ygyno.2005.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To investigate the biological significance of single nucleotide polymorphism (SNP) at Fas gene promoter in cervical carcinogenesis. Methods. SNP at -670 of Fas gene promoter (A/G) together with human papillomavirus (HPV) types were examined in a total of 279 cervical smear samples and 8 human cervical squamous carcinoma cell lines using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) techniques. Results. 49 patients with high-grade squamous intraepithelial lesion (HSIL) had higher frequency of high-risk HPV and GA + GG genotype than 167 with low-grade SIL (LSIL) and 63 controls. G allele frequency was also higher in HSIL than in LSIL and controls. There was an increased OR (6.00; CI, 1.32-27.37; P = 0.021) for GA + GG genotype in HSIL cases compared to controls among 96 patients with high-risk HPV. 7 of 8 cervical carcinoma cell lines also showed GA or GG genotype. Conclusion. Fas gene promoter -670 polymorphism (A/G) may be closely associated with cervical carcinogenesis in a Japanese population. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 28 条
[1]  
[Anonymous], ACTA OBST GYNAEC JPN
[2]   Thyroid papillary carcinoma:: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene [J].
Basolo, F ;
Giannini, R ;
Faviana, P ;
Fontanini, G ;
Malizia, AP ;
Ugolini, C ;
Elisei, R ;
Miccoli, P ;
Toniolo, A .
JOURNAL OF ENDOCRINOLOGY, 2004, 182 (03) :479-484
[3]   Down regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement [J].
Butler, LM ;
Hewett, PJ ;
Butler, WJ ;
Cowled, PA .
BRITISH JOURNAL OF CANCER, 1998, 77 (09) :1454-1459
[4]   Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes [J].
Contreras, TN ;
Krammer, PH ;
Potkul, PK ;
Bu, P ;
Rossi, JL ;
Kaufmann, AM ;
Gissmann, G ;
Qiao, LA .
JOURNAL OF IMMUNOTHERAPY, 2000, 23 (01) :67-74
[5]  
Das H, 2000, BRIT J CANCER, V82, P1682
[6]  
Dybikowska A, 2004, INT J MOL MED, V14, P475
[7]   No evidence of the involvement of the Fas-670 promoter polymorphism in cervical cancer in situ [J].
Engelmark, MT ;
Renkema, KY ;
Gyllensten, UB .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) :1084-1085
[8]   Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients [J].
Huang, QR ;
Danis, V ;
Lassere, M ;
Edmonds, J ;
Manolios, N .
RHEUMATOLOGY, 1999, 38 (07) :645-651
[9]   Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene [J].
Huang, QR ;
Morris, D ;
Manolios, N .
MOLECULAR IMMUNOLOGY, 1997, 34 (8-9) :577-582
[10]  
Kanemitsu S, 2002, J RHEUMATOL, V29, P1183